293 related articles for article (PubMed ID: 34831015)
1. Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
Eibenschutz L; Caputo S; Camera E; Carbone A; Silipo V; Migliano E; Aurizi C; Cota C; Frascione P; Bellei B
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34831015
[TBL] [Abstract][Full Text] [Related]
2. The Role of Dermal Fibroblasts in Nevoid Basal Cell Carcinoma Syndrome Patients: An Overview.
Bellei B; Caputo S; Carbone A; Silipo V; Papaccio F; Picardo M; Eibenschutz L
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979112
[TBL] [Abstract][Full Text] [Related]
3. Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response.
Gambini D; Passoni E; Nazzaro G; Beltramini G; Tomasello G; Ghidini M; Kuhn E; Garrone O
Front Med (Lausanne); 2022; 9():893063. PubMed ID: 35775005
[TBL] [Abstract][Full Text] [Related]
4. Gorlin Syndrome-Associated Basal Cell Carcinomas Treated with Vismodegib or Sonidegib: A Retrospective Study.
Murgia G; Valtellini L; Denaro N; Nazzaro G; Bortoluzzi P; Benzecry V; Passoni E; Marzano AV
Cancers (Basel); 2024 Jun; 16(12):. PubMed ID: 38927872
[TBL] [Abstract][Full Text] [Related]
5. Tolerance of sonidegib after intolerance of vismodegib-Experience in two patients with nevoid basal cell carcinoma syndrome (Gorlin syndrome).
Venturi F; Trane L; Silvestri F; Zuccaro B; Magnaterra E; De Giorgi V
Skin Health Dis; 2023 Oct; 3(5):e260. PubMed ID: 37799353
[TBL] [Abstract][Full Text] [Related]
6. Nevoid Basal Cell Carcinoma Syndrome:
Martinez MF; Romano MV; Martinez AP; González A; Muchnik C; Stengel FM; Mazzuoccolo LD; Azurmendi PJ
Cells; 2019 Feb; 8(2):. PubMed ID: 30754660
[TBL] [Abstract][Full Text] [Related]
7. PTCH1 +/- dermal fibroblasts isolated from healthy skin of Gorlin syndrome patients exhibit features of carcinoma associated fibroblasts.
Valin A; Barnay-Verdier S; Robert T; Ripoche H; Brellier F; Chevallier-Lagente O; Avril MF; Magnaldo T
PLoS One; 2009; 4(3):e4818. PubMed ID: 19287498
[TBL] [Abstract][Full Text] [Related]
8. Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas.
Wahid M; Jawed A; Mandal RK; Dar SA; Khan S; Akhter N; Haque S
Crit Rev Oncol Hematol; 2016 Feb; 98():235-41. PubMed ID: 26614022
[TBL] [Abstract][Full Text] [Related]
9. From basal cell carcinoma morphogenesis to the alopecia induced by hedgehog inhibitors: connecting the dots.
Dessinioti C; Antoniou C; Stratigos AJ
Br J Dermatol; 2017 Dec; 177(6):1485-1494. PubMed ID: 28626889
[TBL] [Abstract][Full Text] [Related]
10. Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas.
Jain S; Song R; Xie J
Onco Targets Ther; 2017; 10():1645-1653. PubMed ID: 28352196
[TBL] [Abstract][Full Text] [Related]
11. Impairment of Base Excision Repair in Dermal Fibroblasts Isolated From Nevoid Basal Cell Carcinoma Patients.
Charazac A; Fayyad N; Beal D; Bourgoin-Voillard S; Seve M; Sauvaigo S; Lamartine J; Soularue P; Moratille S; Martin MT; Ravanat JL; Douki T; Rachidi W
Front Oncol; 2020; 10():1551. PubMed ID: 32850458
[TBL] [Abstract][Full Text] [Related]
12. Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series.
Wescott R; Samlowski W
Curr Oncol; 2023 Oct; 30(10):9156-9167. PubMed ID: 37887561
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog Pathway in Pediatric Cancers: They're Not Just for Brain Tumors Anymore.
Macdonald TJ
Am Soc Clin Oncol Educ Book; 2012; ():605-9. PubMed ID: 24451804
[TBL] [Abstract][Full Text] [Related]
14. Sonidegib for the Treatment of Advanced Basal Cell Carcinoma.
Brancaccio G; Pea F; Moscarella E; Argenziano G
Front Oncol; 2020; 10():582866. PubMed ID: 33194718
[TBL] [Abstract][Full Text] [Related]
15. Sonic Hedgehog Pathway Inhibition in the Treatment of Advanced Basal Cell Carcinoma.
Leavitt E; Lask G; Martin S
Curr Treat Options Oncol; 2019 Nov; 20(11):84. PubMed ID: 31773379
[TBL] [Abstract][Full Text] [Related]
16. Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.
Puig S; Serra-Guillén C; Pérez-Pastor G; Martínez-Domenech Á; Fernández-de-Misa Cabrera R
Drugs Context; 2022; 11():. PubMed ID: 35677182
[TBL] [Abstract][Full Text] [Related]
17. Strategies to target the Hedgehog signaling pathway for cancer therapy.
Xin M; Ji X; De La Cruz LK; Thareja S; Wang B
Med Res Rev; 2018 May; 38(3):870-913. PubMed ID: 29315702
[TBL] [Abstract][Full Text] [Related]
18. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib.
Danial C; Sarin KY; Oro AE; Chang AL
Clin Cancer Res; 2016 Mar; 22(6):1325-9. PubMed ID: 26546616
[TBL] [Abstract][Full Text] [Related]
19. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma.
Tampa M; Georgescu SR; Mitran CI; Mitran MI; Matei C; Scheau C; Constantin C; Neagu M
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32961989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
